Related Experiment Video
Updated: Aug 5, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells
P A Craven1, R K Studer, J Felder
1Department of Medicine, University of Pittsburgh, Pennsylvania, USA. pcraven@unixs.cis.pitt.edu
Abstract:
Culture of mesangial cells (MCs) in 5.6 vs. 30.0 mmol/l glucose for 3 weeks induced a sustained increase in protein kinase C (PKC) activity, transforming growth factor (TGF)-beta1 mRNA, bioactive TGF-beta, and collagen synthesis. Nitric oxide (NO), generated exogenously by the NO donor S-nitroso-N-acetyl, D,L-penicillamine (SNAP) or endogenously after the exposure of MC to interleukin-1beta (IL-1beta), suppressed bioactive TGF-beta in MCs cultured in 5.6 or 30.0 mmol/l glucose and suppressed or abolished increases in TGF-beta1 mRNA and collagen synthesis induced by high concentrations of glucose or phorbol 12,13-dibutyrate without altering values obtained with normal glucose concentrations. SNAP had a transient suppressive effect on PKC activity, which may explain at least in part some of the actions of SNAP. The selective inhibitor of PKC, bisindolylmaleimide (GFX), mimicked NO action. The ability of SNAP and IL-1beta to suppress TGF-beta and collagen synthesis was not mediated by cGMP, since the cGMP analog, 8-Br-PET-cGMP, did not mimic NO action and an antagonist of cGMP-dependent protein kinase, Rp-8-pCPT-cGMPs, did not prevent the inhibitory actions of SNAP. N-omega-L-arginine methyl ester (NMMA) increased TGF-beta in glomerular capillary endothelial cells (GCECs) and stimulated collagen synthesis by MC in a co-culture with GCECs. Captopril inhibited TGF-beta and collagen synthesis and increased cGMP in co-cultures of GCECs and MCs. These effects of captopril were abolished by NMMA, implying mediation by NO. Thus, endogenous NO produced by GCECs may modulate TGF-beta production by both GCECs and MCs and act to suppress matrix protein synthesis by MCs.
Insights
High glucose increases protein kinase C (PKC) and transforming growth factor-beta1 (TGF-beta1) in mesangial cells. Nitric oxide (NO) suppresses these effects, suggesting a protective role in kidney disease.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- High glucose concentrations induce cellular changes in the kidney, contributing to diabetic nephropathy.
- Transforming growth factor-beta1 (TGF-beta1) and collagen synthesis are key mediators of kidney damage in diabetes.
- Protein kinase C (PKC) activity is implicated in the pathogenesis of diabetic complications.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) in modulating TGF-beta1 and collagen synthesis in mesangial cells under high glucose conditions.
- To explore the signaling pathways involved, including PKC and cGMP.
Main Methods:
- Mesangial cells (MCs) and glomerular capillary endothelial cells (GCECs) were cultured under varying glucose concentrations (5.6 vs. 30.0 mmol/l).
- Effects of NO donors (SNAP), NO-inducing agents (IL-1beta), PKC inhibitors (GFX), and NO synthesis inhibitors (NMMA) were assessed.
- TGF-beta1 mRNA, bioactive TGF-beta, collagen synthesis, and PKC activity were measured.
- cGMP analogs and antagonists were used to investigate cGMP mediation.
Main Results:
- High glucose (30.0 mmol/l) sustained increased PKC activity, TGF-beta1 mRNA, bioactive TGF-beta, and collagen synthesis.
- Exogenous and endogenous NO (via SNAP and IL-1beta) suppressed TGF-beta and collagen synthesis induced by high glucose or phorbol ester.
- NO's effects were not mediated by cGMP.
- PKC inhibition mimicked NO's suppressive actions.
- NMMA increased TGF-beta and collagen synthesis, while captopril inhibited them, with effects mediated by NO.
Conclusions:
- Endogenous NO, particularly from GCECs, plays a crucial role in suppressing TGF-beta production and matrix protein synthesis in MCs.
- NO acts as a protective factor against high glucose-induced kidney damage by inhibiting TGF-beta and collagen synthesis.
- Targeting NO pathways may offer therapeutic strategies for diabetic nephropathy.
More Related Videos
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Nitric Oxide Signaling Pathway